Employer record no. 23630
Capstan Therapeutics, Inc
US DOL LCA disclosure data, FY2022 to FY2025
Total LCA filings
12
Certified
12
Denied
0
FY2025 filings
2
Filings by fiscal year
Peer rank
#2,208 of 2,686 healthcare employers by filings
The ledger
| Fiscal year | Filed | Certified | Denied | Avg offered wage | Avg prevailing |
|---|---|---|---|---|---|
| FY2022 | 5 | 5 | 0 | $140,880 | $119,775 |
| FY2023 | 2 | 2 | 0 | $89,988 | $70,710 |
| FY2024 | 3 | 3 | 0 | $117,761 | $99,909 |
| FY2025 | 2 | 2 | 0 | $206,495 | $189,530 |
What they file for
- senior scientist$113,3333
- associate director, analytical development$142,4591
- director, head of mrna drug substance$198,3701
- director, program management$176,0301
- principal scientist, immunology$150,0001
- research associate, mrna production$79,9761
- scientist, formulation & process development$80,0001
- senior scientist, rna platform$70,8241
Where
- san diego, ca10
- la jolla, ca1
- philadelphia, pa1
Every number on this page is free. Members get an email when this employer files again, a CSV of the full record, and the complete rankings with state and job-title filters.
Watch this employerGet the quarterly H-1B update, free
When DOL publishes new filings we send what changed: the biggest movers and the slimmest wage premiums. No account needed. Members also get alerts for Capstan Therapeutics, Inc and any other employer they watch.
Certification rate 100.0%How these numbers are computed